Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2004
10/21/2004US20040209921 CXCR4 chemokine receptor binding comounds
10/21/2004US20040209917 Pyridinyl derivatives for the treatment of depression
10/21/2004US20040209873 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals
10/21/2004US20040209872 Calcium channel blockers comprising two benzhydril moieties
10/21/2004US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example
10/21/2004US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/21/2004US20040209847 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders
10/21/2004US20040209765 Substituted pyridyl amine catalysts and processes for polymerizing and polymers
10/21/2004US20040205907 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness
10/21/2004CA2521875A1 Calcium channel blockers comprising two benzhydril moieties
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/21/2004CA2521416A1 Polyamine compounds for treating chemokine receptor mediated diseases
10/21/2004CA2521184A1 Novel compounds and compositions as protein kinase inhibitors
10/21/2004CA2520611A1 Hydroxamic acid compounds and methods of use thereof
10/21/2004CA2517486A1 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides
10/20/2004EP1468049A1 Yellow cationic dyes for dying of organic material
10/20/2004EP1467999A1 Oxothieno[3,2-b]pyridinecarboxamides as antiviral agents
10/20/2004EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004EP1467967A1 Compounds for modulating cell proliferation
10/20/2004EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
10/20/2004EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004EP1443045A9 Carbanilide used as pesticide
10/20/2004EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators
10/20/2004EP1157005B1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2004EP1062249B1 Polymerisation catalysts
10/20/2004EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity
10/20/2004EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments
10/20/2004CN1538959A Fused-polycyclic compounds
10/20/2004CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004CN1538950A Method for producton of amines by reductive amination of carbonyl compounds under transfer-hydrogemation conditons
10/20/2004CN1171875C Uracil substituted phenyl sulfamoyl carboxamides
10/20/2004CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides
10/20/2004CN1171859C Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compound fungicide
10/19/2004US6806372 New orange couplers for use in oxidative hair dyeing compositions and systems
10/19/2004US6806371 Preparation of substituted pyridine N-oxide compounds
10/19/2004US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004US6806369 N-formyl-n-hydroxy-2-(5-isoquinolinoxy)ethylamine anti-bacterial compounds
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/17/2004CA2464604A1 Organic luminescent compounds and methods of making and using same
10/17/2004CA2425817A1 Organic luminescent compounds and methods of making and using same
10/14/2004WO2004087667A1 Ester derivatives of (pyridinyloxy-phenyl)-methanol and process of preparation thereof
10/14/2004WO2004087666A1 Novel n-substituted 2-aminopyridine derivatives
10/14/2004WO2004087665A1 Novel 6-substituted 2-aminopyridine derivatives
10/14/2004WO2004087664A1 Process for preparing 2,6-divinylpyridine and 2-methyl-6-vinylpyridine from 2,6-lutidine over modified zeolites
10/14/2004WO2004087310A1 Ti-pillared clay based vandia catalyst and process for preparation
10/14/2004WO2004087048A2 Benzamide modulators of metabotropic glutamate receptors
10/14/2004WO2004056727A3 Process of making chalcone derivatives
10/14/2004WO2004052291A3 Pyridines for treating injured mammalian nerve tissue
10/14/2004WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
10/14/2004WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
10/14/2004US20040204454 Lactam-containing cyclic diamines and derivatives as factor Xa inhibitors
10/14/2004US20040204451 Prevention reproduction of virus
10/14/2004US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004US20040204436 Imidazonaphthyridines
10/14/2004US20040204422 N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
10/14/2004US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
10/14/2004US20040204375 Gene delivery compounds
10/14/2004US20040200010 Dyeing keratin fibers using developer ,coupler, oxidizer
10/14/2004DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4
10/14/2004CA2519954A1 Benzamide modulators of metabotropic glutamate receptors
10/13/2004EP1466906A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/13/2004EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1466506A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/13/2004EP1466032A1 Volatile copper(ii) complexes for deposition of copper films by atomic layer deposition
10/13/2004EP1465892A1 Glycinamides as factor xa inhibitors
10/13/2004EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/13/2004EP1465869A1 Modulators of lxr
10/13/2004EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
10/13/2004EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
10/13/2004EP1465595A2 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004EP1280797B1 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1206436B1 Retinoids for the treatment of emphysema
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004EP1064265B8 Synthesis of 3-amino-2-chloro-4-methylpyridine from malononitrile and acetone
10/13/2004EP0999204B1 Novel compound having effect of promoting neuron differentiation
10/13/2004EP0934928B1 Cyclic amine derivatives
10/13/2004EP0736036B1 Kininogen inhibitors
10/13/2004CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
10/13/2004CN1537101A Pyridine matrix metalloproteinase inhibitors
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1537087A Method for producing monocarbonyl compounds or biscarbonyl compound or hydroxyl compounds
10/13/2004CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
10/13/2004CN1536994A Hypoglycemic agent
10/13/2004CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols
10/13/2004CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004CN1170826C Amide compounds
10/13/2004CN1170820C 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl1]ethanone and method for its preparation
10/13/2004CN1170814C Amide compounds for potentiation of cholinergic activity
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use